Black Rock Inc. 180 Life Sciences Corp. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.12 - $1.31 $243 - $2,659	-2,030 Reduced 0.55%	365,067 $243,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $2.53 $986 - $3,081	-1,218 Reduced 0.33%	367,097 $310,000
Q1 2022 May 12, 2022	BUY	$2.53 - $3.9 $2,393 - $3,689	946 Added 0.26%	368,315 $954,000
Q4 2021 Feb 10, 2022	BUY	$3.27 - $6.38 $413,838 - $807,427	126,556 Added 52.55%	367,369 $1.43 Million
Q3 2021 Nov 09, 2021	SELL	$5.11 - $10.81 $128,787 - $272,444	-25,203 Reduced 9.47%	240,813 $1.3 Million
Q2 2021 Aug 11, 2021	BUY	$6.7 - $11.98 $1.78 Million - $3.19 Million	266,016 New	266,016 $2.66 Million

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.